Accelerated aging

Encyclopedia of Gerontology

Volumn , Issue , 2007, Pages 10-20

  Sierra, F ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862528020     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-12-370870-2/00002-0     Document Type: Chapter

References (18)

1. Anisimov V.N. Aging and cancer in transgenic and mutant mice. Frontiers in Bioscience 2003, 8:s883-s902.
2. Blasco M.A. Telomeres in cancer and aging: lessons from the mouse. Cancer Letters 2003, 194:183-188.
3. Chang S. A mouse model of Werner syndrome: what can it tell us about aging and cancer?. International Journal of Biochemistry and Cell Biology 2005, 37:991-999.
4. Cheong C., Hong K.U., Lee H.W. Mouse models for telomere and telomerase biology. Experimental and Molecular Medicine 2003, 35:141-153.
5. Cowen T, Tatar M, and Melov S (eds.) (2004) Head-to-head debate on the utility of short-lived animal models for aging: pros and cons. Aging Cell 3: 45-69.
6. de Magalhaes J.P., Cabral J.A., Magalhaes D. The influence of genes on the aging process of mice: a statistical assessment of the genetics of aging. Genetics 2005, 169:265-274.
7. Dumble M., Gatza C., Tyner S., Venkatachalam S., Donehower L.A. Insights into aging obtained from p53 mutant mouse models. Annals of the New York Academy of Science 2004, 1019:171-177.
8. Hosokawa M. A higher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice. Mechanics of Ageing and Development 2002, 123:1553-1561.
9. Kipling D., Davis T., Ostler E.L., Faragher R.G. What can progeroid syndromes tell us about human aging?. Science 2004, 305:1426-1431.
10. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., Hofer T., Seo A.Y., Sullivan R., Jobling W.A., Morrow J.D., Van Remmen H., Sedivy J.M., Yamasoba T., Tanokura M., Weindruch R., Leeuwenburgh C., Prolla T.A. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005, 309:481-484.
11. Kuro-o M. Disease model: human aging. Trends in Molecular Medicine 2001, 7:179-181.
12. Kurosu H., Yamamoto M., Clark J.D., Pastor J.V., Nandi A., Gurnani P., McGuinness O.P., Chikuda H., Yamaguchi M., Kawaguchi H., Shimomura I., Takayama Y., Herz J., Kahn C.R., Rosenblatt K.P., Kuro-o M. Suppression of aging in mice by the hormone Klotho. Science 2005, 309:1829-1833.
13. Martin G.M. Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects Original Article Series 1978, 14:5-39.
14. Martin G.M. Somatic mutagenesis and antimutagenesis in aging research. Mutation Research 1996, 350:35-41.
15. Smith S.K., Kipling D. The role of replicative senescence in cancer and human ageing: utility (or otherwise) of murine models. Cytogenetic Genome Research 2004, 105:455-463.
16. Takeda T. Senescence-accelerated mouse (SAM): a biogerontological resource in aging research. Neurobiology of Aging 1999, 20:105-110.
17. Wallace D.C. Mouse models for mitochondrial disease. American Journal of Medical Genetics 2001, 106:71-93.
18. Warner H.R., Sierra F. Models of accelerated ageing can be informative about the molecular mechanisms of ageing and/or age-related pathology. Mechanics of Ageing and Development 2003, 124:581-587.